146P Stereotactic body radiotherapy plus anlotinib ± toripalimab in untreated oligometastatic brain metastases NSCLC patients. (December 2022) - Han, G.; Bi, J.; Ma, J.; Yuan, M.; Li, Y.; Pi, G.; Li, Y.; Hu, D.